Simcere Pharmaceutical Group
DelistedCIK 1384360fmd_0Q572MCM3ZMSTTHNE36A8SVWSQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2012, 4 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|
| Cost of revenue | 321 | 342 | 328 | 361 |
| Gross profit | 1,536 | 1,799 | 1,712 | 1,722 |
| Research and development | 133 | 126 | 199 | 229 |
| Selling, general and administrative | 1,225 | 1,456 | 1,420 | 1,397 |
| Operating income | 102 | 218 | 144 | 40 |
| Interest expense | 12 | 20 | 42 | 69 |
| Interest and investment income | 9 | 4 | 5 | 4 |
| Income before taxes | 46 | 195 | 116 | (20) |
| Income tax expense | 17 | 11 | (35) | (6) |
| Net income from continuing operations | 29 | 185 | 152 | (14) |
| Net income | 26 | 172 | 178 | 57 |